| Similar Articles |
|---|
 |
BusinessWeek
August 30, 2004
Gene G. Marcial |
PSS Is Really Delivering The Goods When David Smith took the CEO job at PSS World Medical in 2000, sales stood at $160 million. They've since rocketed to $1.35 billion. No wonder industry giants are eyeballing the company: They hope Smith will sell.   |
BusinessWeek
April 23, 2009
Catherine Arnst |
Doctors' Pride: A Hurdle to Digital Medicine A forerunner in New England found that some physicians would sooner cut ties than see their elite status threatened. |
The Motley Fool
December 22, 2010
Seth Jayson |
Here's How McKesson Is Making So Much for You With TTM margins all at a five-year high, McKesson looks like it's doing great. |
The Motley Fool
October 8, 2007
Billy Fisher |
McKesson Expands Its Empire A new acquisition strengthens the company's presence in the cancer drug market. Investors, take note. |
The Motley Fool
November 9, 2005
W.D. Crotty |
McKesson Fattens Its Margins The pharma distributor turns in an outstanding second quarter. Because McKesson is a broadly based supplier, it avoids the roller-coaster impact that specific drug successes and failures have on drug-developer stocks. |
Fast Company
Elizabeth Segran |
Doctor Visits Are So 2014 For scrappy startups, going up against the health care system sometimes seems like an impossible task. But fortunately, major players in the industry, such as McKesson, are pushing for change as well |
The Motley Fool
May 6, 2008
Steven Renaldi |
McKesson Garners Generic Growth New products offer the generic-drug distributor profit potential in a competitive industry. |
The Motley Fool
August 24, 2010
David Meier |
Can McKesson Produce Big Returns? McKesson uses its production advantage -- high asset turnover and reasonable leverage -- to generate very attractive returns on equity for shareholders. |
The Motley Fool
January 2, 2004
Alyce Lomax |
A Bitter Pill for Amerisource Veterans ditch Amerisource for rival; investors punish the entire pharmaceutical distribution industry. |
The Motley Fool
February 1, 2006
Rich Duprey |
Candela Is Finally White Hot The aesthetic laser maker finally produces the white-hot sales growth it promised -- two years ago. In midday trading, the stock soared 30%. |
The Motley Fool
August 2, 2006
Tom Taulli |
Emageon's Image Problems Shares of Emageon, which develops technologies to cost-effectively manage medical images, rose sharply at the start of the year, reaching $19 apiece. Since then, the stock has steadily slid back to $14.58. But the company continues to grow. |
The Motley Fool
May 7, 2004
Mark Mahorney |
WebMD Not a Sure Winner WebMD, providers of online health information, electronic data interchange services and practice management software and services to the healthcare industry, improved slightly during the first quarter, and it looks to be more of the same ahead. |
Pharmaceutical Executive
August 1, 2005
Lena Chow |
Docs of Shanghai They're short on status, pay, and respect, but China's young doctors hold keys to the world's fastest growing pharmaceutical market. |
The Motley Fool
May 28, 2004
Richard Gibbons |
Quality Systems a Picture of Health Earnings are great, but can the medical systems developer maintain its torrid growth rate? |
Managed Care
August 2006
John Carroll |
Everyone Uses E-mail Now (Except Doctors and Patients) The doctors in GreenField Health's primary care network learned years ago that e-mail could often satisfy a regular patient's need for medical advice. Here's how the process works today, who pays for it, and when and why it makes sense. |
The Motley Fool
August 24, 2011
Brandon Glenn |
Cardinal Health Sees Opportunity (but Faces Challenges) in Specialty Drugs Is Cardinal up for the challenge? |
The Motley Fool
September 9, 2009
Brian Orelli |
Don't Like High Drug Costs? Blame Canada. Through a combination of price controls instituted by the Patented Medicine Prices Review Board, and through government negotiations, Canada is able to keep its drug costs down for its citizens. But that doesn't make it right. |
The Motley Fool
May 21, 2007
Anders Bylund |
Foolish Forecast: Svelte Tech Data The tech equipment distributor is set to reports its quarterly earnings. Investors, here is what you can expect to find. |
The Motley Fool
October 25, 2004
Tom Taulli |
McKesson Gets Pain Relief Drug distributors would like to forget 2004. But this may mean bargains for investors. |
The Motley Fool
March 9, 2005
W.D. Crotty |
WebMD's Misleading Results WebMD reports good numbers, but the stock looks pricey. |
